The Latin America, Middle East and Africa Thyroid Ablation Devices Market would witness market growth of 17.0% CAGR during the forecast period (2022-2028).
Patients who are not surgical candidates benefit greatly from local and regional therapy using ablative technologies. RFA and MWA are the most significant thermal ablative systems, although other heat-ablative technologies like laser and HIFU also play a significant role in suppressing tumors. Microwave ablation has good technical performance and is less subject to the heat sink effect in circulatory organs like the liver and kidney and instead provides a uniform and bigger ablation zone.
With efforts to individualise treatment based on the nodule's aetiology and patient performance level, thyroid nodule treatment has considerably changed in recent years. The hazards and side effects of radioactive iodine and surgery have raised interest in alternative therapies including radiofrequency ablation (RFA). The main drivers of the market for thyroid ablation devices are the rise in government funding for the treatment of Hashimoto's thyroiditis and the surge in demand for efficient therapies. In addition, important players who offer a variety of ablation products for the treatment of thyroid cancer, like Theraclion and Sonacare Medical, also contribute to the market's expansion.
In 2020, western Africa was one of the regions where the age-standardized incidence rate (ASIR) of thyroid cancer was high. Age-standardized DALY rate for North Africa and the Middle East was 14.9 per 100,000 people in 2019, with an ASIR of 3.5 and a DALY rate that increased from 1990 to 2019. Health system outcomes in the Middle East and North Africa region vary, according to a health system evaluation. Furthermore, individuals from this region are diagnosed to be more susceptible than others to thyroid cancer risk factors. Reporting the prevalence of thyroid cancer, therefore, assists health policymakers in allocating resources for disease control and prevention activities in the region. This supports the growth of the regional market.
The Brazil market dominated the LAMEA Thyroid Ablation Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $5,006.3 Thousands by 2028. The Argentina market is experiencing a CAGR of 17.6% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 16.7% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Specialty Centers and Others. Based on Type, the market is segmented into Radiofrequency Ablation, Microwave Ablation and Others. Based on Application, the market is segmented into Thyroid Cancer and Thyroid Nodules. Based on Product, the market is segmented into Thermal-based Devices and Non-thermal-based Devices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Thyroid Ablation Devices Market is Predict to reach $289.9 Million by 2028, at a CAGR of 13%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
By End-use
By Type
By Application
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 